1. kschaver
2. sdal3584
3. swedencup494
4. ghostgt
5. dacguvnor
1.sdal3584 03/05/2018
up 33.9% Nice!
2.kschaver 01/26/2018
Trovagene Announces Initiation of UNITE Phase 2 Clinical Trial of PCM-075 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
3.kschaver 03/05/2018
Announced that the initial patient successfully completed the first cycle 1 of treatment in its Phase 1b/2 m…
4.kschaver 02/12/2018
Trovagene Presents Data Showing Synergy of PCM-075 in Combination with Zytiga® in Castration-Resistant Prostate Cancer Model at 2018 Genitourinary Cancers Symposium
5.kschaver 04/19/2018
Trovagene Presents Data at AACR Meeting 2018 on Pharmacodynamic and Tumor Biomarkers During Treatment with PCM-075 and Low-Dose Cytarabine
6.sdal3584 06/08/2018
Trovagene (TROV): Shoring up the Balance Sheet by Selling Shares Comes with a Price
7.kschaver 02/07/2018
Trovagene Announces Completion of Cycle-One Dosing in First Patient Enrolled in its Phase 1b/2 Clinical Trial of PCM-075 in Acute Myeloid Leukemia (AML)
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW